Novel Anti-cancer Compounds for Developing Combinatorial Therapies to Target Anoikis-Resistant Tumors

Author： Nagaprashantha Lokesh   Vartak Neha   Awasthi Sangeeta   Awasthi Sanjay   Singhal Sharad  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.29, Iss.3, 2012-03, pp. : 621-636

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NHE-1: A Promising Target for Novel Anti-cancer Therapeutics

By  

Current Pharmaceutical Design, Vol. 18, Iss. 10, 2012-04 ,pp. : 1372-1382

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Approach to Anticancer Therapies: Peroxisome Proliferator Activator-Receptor-&ggr; as a New Target Therapy in the Treatment of Human Urological Cancer

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 9, Iss. 1, 2009-03 ,pp. : 76-83

Bentham Science Publishers

Access to resources Recommend Favorite

Plant Polyphenols and Tumors: From Mechanisms to Therapies, Prevention, and Protection Against Toxicity of Anti-Cancer Treatments

By  

Current Medicinal Chemistry, Vol. 16, Iss. 30, 2009-01 ,pp. : 3943-3965

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Anti-Cancer Therapies for Renal Cancer

By Amato Robert J.   Jac Jaroslaw  

Drugs, Vol. 66, Iss. 17, 2006-01 ,pp. : 2161-2171

Adis International

Access to resources Recommend Favorite

Listeria monocytogenes as a Vector for Anti-Cancer Therapies

By  

Current Gene Therapy, Vol. 10, Iss. 1, 2010-01 ,pp. : 46-55

Bentham Science Publishers

Access to resources Recommend Favorite